Is AbbVie (ABBV) a Buy Right Now?
A plain-English read on AbbVie stock — what the chart and the numbers are saying today, with no jargon and no hype.
What this means, in plain English
AbbVie is currently priced at $253.38. The stock is in an uptrend, meaning it is trading above its 200-day average of $223.31. This 200-day average acts as a long-term gauge of price direction.
The RSI, or Relative Strength Index, sits at 62.1. This is a gauge of whether a stock has climbed too far, too fast, and this level suggests steady momentum without being extreme. The price remains between its recent floor of $231.3 and its ceiling of $261.64.
Should you buy AbbVie stock?
The data supports a buy position as the stock maintains its upward trend. However, always consider your own risk tolerance before entering a position at the current price of $253.38.
Is ABBV a good stock for beginners?
AbbVie is a large company, but its P/E ratio of 107.4 indicates a high price relative to its earnings. Beginners should note that volatility can occur, especially when a stock trades near its 52-week high of $261.64.
What's driving ABBV right now
The stock is currently trading above its 200-day average of $223.31.
The P/E ratio, a measure of price versus earnings, is currently 107.4.
The recent support level, or price floor, is established at $231.3.
The stock is trading near its 52-week resistance, or ceiling, of $261.64.
The numbers behind the read
With the price holding above its 200-day average of $223.31, the current data favors a buy for those comfortable with the stock's recent performance.
Don't guess. Practice this trade first.
Buy it with virtual cash and watch how it plays out — before a dollar of your own is on the line.
Practice ABBV risk-free in your paper portfolioPaper trading, the AI Read & live indicators are inside a Money GPS membership — one price, the whole platform.
Beginner questions about ABBV
Should I buy ABBV stock?+
The current data shows an upward trend with the price at $253.38, which supports a buy decision.
Is ABBV a good long-term investment?+
The stock is currently above its 200-day average of $223.31, indicating a long-term trend that remains positive.
Is ABBV a buy or a sell?+
Based on the trend and support levels, the data currently points toward a buy.
Is ABBV overvalued?+
With a P/E ratio of 107.4, the stock is priced high relative to its earnings.
Is ABBV a good stock for beginners?+
Beginners should be aware of the 52-week range of $187.62 to $261.64, which shows the price volatility over the last year.
Important disclaimer
This page is for educational and informational purposes only and is not financial, investment, tax, or legal advice, nor a recommendation, offer, or solicitation to buy, sell, or hold AbbVie (ABBV) or any other security. The Money GPS is not a registered investment adviser, broker-dealer, or financial planner, and no content here should be relied upon to make an investment decision.
The verdict, indicators, and commentary are generated automatically — in part using AI — from third-party market data (via Yahoo Finance) that may be delayed, incomplete, or inaccurate, and is provided “as is” without any warranty. Figures reflect the market as of 2026-07-20 and change constantly; the read above may already be out of date. A “Buy,” “Hold,” or “Be Careful” label is a simplified, rules-based signal for beginners — not a price target or a guarantee of any outcome.
All investing involves risk, including the possible loss of your entire principal. Past performance and historical patterns do not guarantee future results. Always do your own research and consult a licensed financial professional who knows your personal circumstances before investing. You are solely responsible for your own investment decisions. The Money GPS and its authors may hold positions in the securities discussed and accept no liability for any loss arising from the use of this information.